Skip to main content

Day: August 23, 2021

Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine

Based on successfully achieving certain milestones primarily related to the execution of a Phase 3 trial and development of large-scale manufacturing processes, Bavarian Nordic will be eligible to receive up to DKK 800 million Agreement aims to strengthen reliability and security of supply of COVID-19 vaccines to meet future revaccination demandsCOPENHAGEN, Denmark, August 23, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company has entered a funding agreement with the Danish Ministry of Health to further advance the development of ABNCoV2, the Company’s COVID-19 vaccine candidate. The agreement is valued at up to DKK 800 million and aims to support the completion of the development towards licensure of ABNCoV2 as a booster vaccine, which could help strengthen the reliability and security of supply of COVID-19 vaccines...

Continue reading

Athira Pharma to Present on ERP P300 as a Direct, Functional, Non-Invasive Biomarker at the Annual Biomarkers for Alzheimer’s Disease Summit

BOTHELL, Wash., Aug. 23, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that Chief Medical Officer, Hans Moebius, will present on the application of clinically established Evoked-Response Potentials (ERPs) by using ERP P300 in Alzheimer’s drug development, and the utility of ERP P300 in Athira’s Phase 1 clinical trials, at the Annual Biomarkers for Alzheimer’s Disease Summit taking place virtually August 24-26, 2021. Presentation Details: Title: Advances in Direct, Functional, Non-Invasive Biomarkers; Athira’s Utilization of ERP P300Presenter: Hans J. Moebius, MD, PhD, Chief Medical Officer, Athira Pharma, Inc.Date: Wednesday, August 25, 2021Time: 12:10 p.m. PT...

Continue reading

Salona Global Medical Device Corporation Announces Plans to Launch Intellectual Property Acquisition Unit; Complete Transaction with a Multi-Product, IP-Driven Medical Device Company with $8,000,000 in 2020 Revenues

NOT FOR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION OVER UNITED STATES ‎NEWSWIRES.‎ SAN DIEGO, Aug. 23, 2021 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (the “Company” or “SGMD”) (TSXV:SGMD) announced today a plan to launch an intellectual property (IP) business unit through a transaction with a business that has a portfolio of several revenue and royalty generating products ranging from wearable technology to products for physical stability as well as expertise in development and design of many medical devices it has innovated over the past several years (the “Target”). The cash flow positive Target, which generated $8,000,000 in revenues in 2020 with 50% gross margins, develops IP and designs cutting edge medical devices in very specific, targeted markets (such as the sports medicine industry) on behalf...

Continue reading

TopBuild Acquires Valley Gutter Supply

Supplier of gutter and other building products to contractors in Los Angeles DAYTONA BEACH, Fla., Aug. 23, 2021 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD) a leading installer and distributor of insulation and building material products in the United States, has acquired Valley Gutter Supply, a fabricator and distributor of gutter products and specialty metals to contractors in the Los Angeles area. Founded in 2007, 70% of Valley Gutter’s customers serve the residential market with the remainder focused on light commercial. Valley Gutter generated approximately $10 million in revenue for the trailing twelve months ended June 30, 2021. Robert Buck, President and CEO of TopBuild, noted, “We are pleased to welcome Valley Gutter to our team. This firm is an excellent addition to our Company and will enhance Service Partner’s gutter...

Continue reading

Bitcoin Well Announces Second Quarter 2021 Financial Results Highlighted by Revenue Growth of 405%

EDMONTON, Alberta, Aug. 23, 2021 (GLOBE NEWSWIRE) — Bitcoin Well Inc. (TSXV: BTCW) (“Bitcoin Well” or the “Company”) today announced our financial and operating results for the second quarter and first half of 2021. The interim Financial Statements and Notes, as well as Management’s Discussion and Analysis (“MD&A”) for the three and six month periods ended June 30, 2021 and 2020 are available on our website and have been filed on SEDAR. “I am excited to share the numerous transformational milestones achieved by Bitcoin Well during the second quarter. We enhanced our Board of Directors, closed a $7 million private placement financing, and opened an over-the-counter (“OTC”) office in Calgary. We have also continued to expand, including the international acquisition of a UK bitcoin ATM operator,” said Adam O’Brien, Founder and...

Continue reading

Alpine Income Property Trust Increases Quarterly Dividend By 2.0% and Declares Dividend for the Third Quarter 2021

DAYTONA BEACH, Fla., Aug. 23, 2021 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors has authorized, and the Company has declared, an increase in the Company’s quarterly cash dividend to $0.255 per share of common stock for the third quarter of 2021 from its previous quarterly cash dividend of $0.25 per share of common stock. The dividend is payable on September 30, 2021 to stockholders of record as of the close of business on September 9, 2021. The 2021 third quarter cash dividend represents a 2.0% increase over the Company’s previous quarterly dividend and an annualized yield of approximately 5.5% based on the closing price of the common stock on August 20, 2021. About Alpine Income Property Trust, Inc. Alpine Income Property Trust, Inc. (NYSE: PINE)...

Continue reading

CTO Realty Growth Declares Quarterly Dividends for the Third Quarter 2021

DAYTONA BEACH, Fla., Aug. 23, 2021 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced today that its Board of Directors has authorized, and the Company has declared a quarterly cash dividend of $1.00 per share of common stock for the third quarter of 2021. The dividend is payable on September 30, 2021 to stockholders of record as of the close of business on September 9, 2021. The 2021 third quarter cash dividend represents an annualized yield of approximately 7.4% based on the closing price of the common stock on August 20, 2021. The Board of Directors also authorized, and the Company has declared, a pro-rated quarterly cash dividend of $0.39630 per share of the Company’s 6.375% Series A Cumulative Redeemable Preferred Stock, to be paid on September 30, 2021 to stockholders of record as of...

Continue reading

Industrial Mezzanines Market: Partnership between Major Companies Such as stow International and Steele Solutions Inc. to Create Exciting Growth Opportunities

List of the Companies Profiled in the Market: Mecalux, S.A.,JungheinrichAG, Schaefer Systems International,Inc, MiTek Mezzanine Systems, Inc, stowInternational, Stanley Black & Decker, Inc, Equipto, Cornerstone Specialty Wood Products, LLC,Equipment Roundup Manufacturing, Cogan Wire andMetal Products Ltd., Cornix, Steele SolutioInc, KeplerEntreplantasDesmontablesS.L,Noordrek, Konvex Storage Systems, S.L,Panel Built, Inc, Gonvarri Material Handling, ShanghaiMaxrac Storage Equipment Engineering Co., Ltd Pune, India, Aug. 23, 2021 (GLOBE NEWSWIRE) — The global industrial mezzanines market size is expected to showcase considerable growth by reaching USD 10.14 billion by 2028 while exhibiting a CAGR of 4.8% between 2021 and 2028. Fortune Business Insights published this information in its report, titled, “Industrial Mezzanines...

Continue reading

Pfizer to Acquire Trillium Therapeutics Inc.

Proposed acquisition strengthens Pfizer’s category leadership in Oncology with addition of next-generation, investigational immuno-therapeutics for hematological malignancies Expands innovative pipeline, potentially enhancing growth in 2026-2030 and beyond Pfizer to host analyst and investor call at 10:00 a.m. ET today with Pfizer Oncology executives NEW YORK and CAMBRIDGE, Mass., Aug. 23, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. Under the terms of the agreement, Pfizer will acquire all outstanding shares of Trillium not already owned by Pfizer for an implied...

Continue reading

Affimed to Report Second Quarter 2021 Financial Results & Corporate Update on September 8, 2021

HEIDELBERG, Germany, Aug. 23, 2021 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it will release second quarter 2021 results on Wednesday, September 8, 2021, and host a conference call at 8:30 a.m. EDT to discuss financial results and recent corporate developments. The conference call will be available via phone and webcast. To access the call, please dial +1 (409) 220-9054 for U.S. callers, or +44 (0) 8000 323836 for international callers, and reference passcode 6156773 approximately 15 minutes prior to the call. To access the live audio webcast of the conference call please visit the “Investors” section of company’s website at https://www.affimed.com/investors/webcasts_cp/. A replay of the call...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.